Brokerages Set BioNTech SE (NASDAQ:BNTX) Price Target at $157.23

Shares of BioNTech SE (NASDAQ:BNTX – Get Free Report) have received an average rating of “Hold” from the ten ratings firms that are covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price […]

Leave a Reply

Your email address will not be published.

Previous post Regulator acts against PayPal and QVC as more Britons turn to buy now, pay later
Next post GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Consensus Recommendation of “Hold” from Analysts